These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 341853

  • 1. Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites.
    Oesch F, Raphael D, Schwind H, Glatt HR.
    Arch Toxicol; 1977 Dec 30; 39(1-2):97-108. PubMed ID: 341853
    [Abstract] [Full Text] [Related]

  • 2. Dual role of epoxide hydratase in both activation and inactivation of benzo(a)pyrene.
    Bentley P, Oesch F, Glatt H.
    Arch Toxicol; 1977 Dec 30; 39(1-2):65-75. PubMed ID: 341851
    [No Abstract] [Full Text] [Related]

  • 3. Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes.
    Wood AW, Levin W, Lu AY, Yagi H, Hernandez O, Jerina DM, Conney AH.
    J Biol Chem; 1976 Aug 25; 251(16):4882-90. PubMed ID: 821945
    [Abstract] [Full Text] [Related]

  • 4. Differential control of rat microsomal "aryl hydrocarbon" monooxygenase and epoxide hydratase.
    Oesch F.
    J Biol Chem; 1976 Jan 10; 251(1):79-87. PubMed ID: 1244357
    [Abstract] [Full Text] [Related]

  • 5. Prevention of benzo(a)pyrene-induced mutagenicity by homogeneous epoxide hydratase.
    Oesch F, Bentley P, Glatt HR.
    Int J Cancer; 1976 Oct 15; 18(4):448-52. PubMed ID: 10260
    [Abstract] [Full Text] [Related]

  • 6. Microsomal activation of dibenzo[def,mno]chrysene (anthanthrene), a hexacyclic aromatic hydrocarbon without a bay-region, to mutagenic metabolites.
    Platt KL, Degenhardt C, Grupe S, Frank H, Seidel A.
    Chem Res Toxicol; 2002 Mar 15; 15(3):332-42. PubMed ID: 11896680
    [Abstract] [Full Text] [Related]

  • 7. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
    Oesch F, Protić-Sabljić M, Friedberg T, Klimisch HJ, Glatt HR.
    Carcinogenesis; 1983 Aug 15; 4(8):1031-8. PubMed ID: 6347425
    [Abstract] [Full Text] [Related]

  • 8. Mutagenesis of certain activated carcinogens in vitro associated with genetically mediated increases in monooxygenase activity and cytochrome P 1-450.
    Felton JS, Nebert DW.
    J Biol Chem; 1975 Sep 10; 250(17):6769-78. PubMed ID: 808546
    [Abstract] [Full Text] [Related]

  • 9. Significance of various enzymes in the control of mutagenic and carcinogenic metabolites derived from aromatic structures.
    Oesch F.
    Toxicol Pathol; 1984 Sep 10; 12(4):391-6. PubMed ID: 6398501
    [Abstract] [Full Text] [Related]

  • 10. Microsomal mixed-function oxidases and epoxide hydratase convert benzo(a)pyrene stereospecifically to optically active dihydroxydihydrobenzo(a)pyrenes.
    Yang SK, Gelboin HV.
    Biochem Pharmacol; 1976 Oct 01; 25(19):2221-5. PubMed ID: 971337
    [No Abstract] [Full Text] [Related]

  • 11. Transplacental control of epoxide hydratase and its relationship to the control of microsomal monooxygenase.
    Oesch F.
    FEBS Lett; 1975 May 01; 53(2):205-10. PubMed ID: 1140407
    [No Abstract] [Full Text] [Related]

  • 12. Antimutagenesis by shift in monooxygenase isoenzymes and induction of epoxide hydrolase.
    Oesch F.
    Mutat Res; 1988 Dec 01; 202(2):335-42. PubMed ID: 3057365
    [Abstract] [Full Text] [Related]

  • 13. Species differences in activating and inactivating enzymes related to in vitro mutagenicity mediated by tissue preparations from these species.
    Oesch F.
    Arch Toxicol Suppl; 1980 Dec 01; 3():179-94. PubMed ID: 6994685
    [No Abstract] [Full Text] [Related]

  • 14. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW, Wislocki PG, Chang RL, Levin W, Lu AY, Yagi J, Hernandez O, Herina DM, Conney AH.
    Cancer Res; 1976 Sep 01; 36(9 pt.1):3358-66. PubMed ID: 788899
    [Abstract] [Full Text] [Related]

  • 15. Modification of benzo(a)pyrene metabolism in hepatic microsomes from untreated and induced rats by imidazole derivatives which inhibit monooxygenase activity and enhance epoxide hydrolase activity.
    James MO, Little PJ.
    Drug Metab Dispos; 1983 Sep 01; 11(4):350-4. PubMed ID: 6137342
    [Abstract] [Full Text] [Related]

  • 16. Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
    Golan MD, Bücker M, Schmassmann HU, Raphael D, Jung R, Bindel U, Brase HO, Tegtmeyer F, Friedberg T, Lorenz J, Stasiecki P, Oesch F.
    Drug Metab Dispos; 1980 Sep 01; 8(3):121-6. PubMed ID: 6104571
    [No Abstract] [Full Text] [Related]

  • 17. Drug metabolism in man and its relationship to that in three rodent species: monooxygenase, epoxide hydrolase, and glutathione S-transferase activities in subcellular fractions of lung and liver.
    Lorenz J, Glatt HR, Fleischmann R, Ferlinz R, Oesch F.
    Biochem Med; 1984 Aug 01; 32(1):43-56. PubMed ID: 6541908
    [Abstract] [Full Text] [Related]

  • 18. Benzo[a]pyrene diol epoxides: mechanism of enzymatic formation and optically active intermediates.
    Yang SK, McCourt DW, Leutz JC, Gelboin HV.
    Science; 1977 Jun 10; 196(4295):1199-201. PubMed ID: 870975
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of carcinogens, possibilities for modulation.
    Oesch F.
    Acta Pharmacol Toxicol (Copenh); 1984 Jun 10; 55 Suppl 2():15-33. PubMed ID: 6385619
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of benzo(a)pyrene and benzo(a)pyrene 4,5-oxide in rabbit lung.
    Bend JR, Smith BR, Ball LM, Plummer JL, Wolf CR, Philpot RM, Devereux TR, Fouts JR.
    Adv Exp Med Biol; 1981 Jun 10; 136 Pt A():541-54. PubMed ID: 6283815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.